Features of patients with uveitis associated with juvenile idiopathic arthritis required eye surgery

doi:10.5409/wjcp.v14.i4.107290

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

This Article

(39)

(59)

(0)

(9)

(734)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Clinical Pediatrics

ISSN

2219-2808

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Pediatr. Dec 9, 2025; 14(4): 107290
Published online Dec 9, 2025. doi: 10.5409/wjcp.v14.i4.107290

Full Size Figure Download Figure

Figure 1 The flowchart of the study. U-JIA: Uveitis associated with juvenile idiopathic arthritis; MTX: Methotrexate; bDMARDs: Biologic disease-modifying anti-rheumatic drugs.

Citation: Yakovlev AA, Gaidar EV, Sorokina LS, Nikitina TN, Chikova IA, Kalashnikova OV, Kostik MM. Features of patients with uveitis associated with juvenile idiopathic arthritis required eye surgery. World J Clin Pediatr 2025; 14(4): 107290
URL: https://www.wjgnet.com/2219-2808/full/v14/i4/107290.htm
DOI: https://dx.doi.org/10.5409/wjcp.v14.i4.107290

Yakovlev AA, Gaidar EV, Sorokina LS, Nikitina TN, Chikova IA, Kalashnikova OV, Kostik MM. Features of patients with uveitis associated with juvenile idiopathic arthritis required eye surgery. World J Clin Pediatr 2025; 14(4): 107290 [PMID: 41255667 DOI: 10.5409/wjcp.v14.i4.107290]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.